A recent clinical trial conducted in Vietnam has analyzed the effects of photobiomodulation using LED devices among orthodontic patients. This research highlights advancements in managing pain, tooth movement, and root resorption during orthodontic treatment. Medical professionals focused on regulatory compliance and device approvals may find the findings insightful for ongoing developments in orthodontic care.
In this article
What changed?
The study, sponsored by Thanh Thuy-Nhat Cao, compared LED photobiomodulation devices with placebo versions. It focused on core orthodontic concerns such as pain management, root resorption, and tooth movement. The study has been completed, offering valuable data for clinical teams and manufacturers.
Study details
What is photobiomodulation?
Photobiomodulation refers to the therapeutic application of light to stimulate cellular processes. Orthodontic treatments often result in discomfort and biological changes, including localized inflammation and root resorption. This clinical study aimed to address these challenges by comparing outcomes with effective LED devices versus placebo devices.
Conditions targeted
The research focused on pain relief for patients undergoing orthodontic procedures. Tooth movement speed and long-term root health, often impacted during orthodontic care, were also evaluated as key parameters.
Devices tested
The trial tested two devices: an active LED device engineered for photobiomodulation therapy and a placebo LED device designed to simulate use without therapeutic outcomes. Teams should note the distinction in study design between active performance versus non-therapeutic placebo control.
Completion status
The trial has been marked as completed, indicating that the dataset is ready for review and potential application in regulatory submissions or device benchmarks.
Clinical implications
Why is this study significant?
LED-based photobiomodulation could offer a safer, non-invasive alternative for pain relief and root resorption control, key areas in orthodontic device development. It aligns with global trends emphasizing non-pharmaceutical solutions and patient-centered therapy.
Impact on regulatory submissions
Medical teams developing similar devices may leverage the outcomes of this trial to enhance their global compliance submissions. The trial’s completion provides opportunities for alignment with MDR Annex XIV requirements.
FAQ
- What devices were tested?
Two LED devices—a functional photobiomodulation version and a placebo model. - What were the primary focus areas?
Pain management, tooth movement, and root resorption during orthodontic therapy. - Who sponsored the study?
The research was sponsored by Thanh Thuy-Nhat Cao.
Conclusion
Medical device professionals and regulatory teams can now explore the potential applications of LED photobiomodulation therapy for improved orthodontic care. The findings offer insights on pivotal clinical areas, such as pain relief and accelerated recovery. Leveraging these advancements may optimize patient outcomes while meeting regulatory requirements.
Disclaimer
This article provides an informational overview for professionals. It does not constitute legal or regulatory advice and should not replace official guidance documents.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07276984?term=medical+device